Analyst Ratings For AxoGen (NASDAQ:AXGN)
Today, William Blair initiated coverage on AxoGen (NASDAQ:AXGN) with a Outperform.
Some recent analyst ratings include
- 2/5/2018-William Blair initiated coverage with a Outperform rating.
- 11/30/2017-Jefferies Group initiated coverage with a Buy rating.
- 11/21/2017-Wedbush Reiterated Rating of Buy.
- 9/12/2017-Roth Capital Reiterated Rating of Buy.
Recent Insider Trading Activity For AxoGen (NASDAQ:AXGN)
AxoGen (NASDAQ:AXGN) has insider ownership of 9.33% and institutional ownership of 65.94%.
- On 12/12/2017 Jamie Mark Grooms, Director, sold 38,405 with an average share price of $26.35 per share and the total transaction amounting to $1,011,971.75.
- On 12/8/2017 Jamie Mark Grooms, Director, sold 84,295 with an average share price of $26.38 per share and the total transaction amounting to $2,223,702.10.
- On 12/6/2017 Jamie Mark Grooms, Director, sold 21,290 with an average share price of $26.22 per share and the total transaction amounting to $558,223.80.
- On 11/20/2017 Guido J Neels, Director, sold 1,150,000 with an average share price of $19.74 per share and the total transaction amounting to $22,701,000.00.
- On 9/11/2017 Robert James Rudelius, Director, sold 16,143 with an average share price of $18.00 per share and the total transaction amounting to $290,574.00.
- On 10/7/2016 Amy Mcbride Wendell, Director, bought 13,333 with an average share price of $7.50 per share and the total transaction amounting to $99,997.50.
- On 10/7/2016 John P Engels, VP, bought 4,000 with an average share price of $7.50 per share and the total transaction amounting to $30,000.00.
Recent Trading Activity for AxoGen (NASDAQ:AXGN)
Shares of AxoGen closed the previous trading session at with 27.200000762939453 shares trading hands.